For over 20 years, Riverain Technologies has been a relentless innovator that empowers healthcare providers by streamlining diagnostic processes, elevating detection accuracy, and improving the outcomes of patients with cardiothoracic diagnoses. Riverain’s ClearRead™ solutions significantly improve a clinician’s ability to accurately and efficiently detect and analyze cardiothoracic conditions on chest CT and X-ray images.
Meet the leaders of Riverain, united on their mission to revolutionize radiology.
Learn how Riverain’s patented suppression technologies and advanced AI algorithms are driving accuracy, efficiency, and ease of use.
Our dedicated Riverain team is passionate about making a real difference in people’s lives.
Riverain Technologies led early advances in AI-driven medical imaging and continues to propel that technology to even greater heights.
First FDA Approval for Chest X-Ray CAD
Unique Suppression Patent
First FDA Approval for Concurrent Reading
FIRST LUNG CANCER SCREENING CAD SOLUTION WITH UNIVERSAL PACS INTEROPERABILITY
COMPATIBILITY AND VALIDATION WITH EVERY MAJOR AI PLATFORM
Dr. Jared Christensen is vice chair of strategy of the Duke University Department of Radiology and director of the Duke Lung Cancer Screening Program. He currently serves as chair of the American College of Radiology Lung-RADS Committee. Dr. Christensen’s professional interests in AI focus on finding solutions that decrease variability, increase efficiency, and improve patient outcomes.
Dr. Jonathan Chung, Divisional Chief of Cardiothoracic Imaging, University of California San Diego Medical Center, specializes in cardiopulmonary imaging. He analyzes and interprets chest radiographs and CT scans for thoracic diseases. He also has expertise in interstitial lung disease, occupational lung disease, nontuberculous mycobacterial popularity, and diseases of the large and small airways. He has authored over 190 peer-reviewed articles that have been published in scientific journals, co-authored numerous book chapters and seven books that focus on chest diagnostics.
Dr. Charles White has been on the Riverain advisory board since 2013, and is Professor of Radiology and Medicine at the University of Maryland Medical Center. Dr. White has a special interest in the diagnosis and staging of lung cancer and cardiac CT imaging. Dr. White was named one of Baltimore Magazine’s 2010 “Top Docs” for General Diagnostic Radiology.
To eliminate delayed cardio-thoracic disease diagnoses.
To be recognized as a transformative leader in the thoracic sciences.
